Neuronetics, inc. (STIM)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Revenues

61,404

62,656

0

0

0

-

-

-

-

-

-

-

-

Cost of revenues

15,393

15,389

0

0

0

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

40,433

0

0

0

Cost of revenues

-

-

-

-

-

-

-

-

-

9,632

0

0

0

Gross Profit

46,011

47,267

46,054

44,949

42,555

40,329

37,556

34,708

32,508

30,801

0

0

0

Operating expenses:
Sales and marketing

44,124

42,993

42,125

41,435

39,747

38,264

36,244

33,138

29,703

27,900

0

0

0

General and administrative

18,145

17,457

17,860

16,813

15,630

13,667

11,789

10,807

9,566

8,572

0

0

0

Research and development

13,982

13,747

11,721

10,357

9,463

8,232

7,929

7,647

7,464

7,937

0

0

0

Total operating expenses

76,251

74,197

71,706

68,605

64,840

60,163

55,962

51,592

46,733

44,409

0

0

0

Loss from Operations

-30,240

-26,930

-25,652

-23,656

-22,285

-19,834

-18,406

-16,884

-14,225

-13,608

0

0

0

Other (income) expense:
Interest expense

4,289

3,685

3,719

3,717

3,686

3,688

3,489

3,368

3,179

2,808

0

0

0

Other (income) expense, net

1,325

1,571

1,738

1,646

-158

-575

-983

-1,418

362

357

0

0

0

Loss on extinguishment of debt

0

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-34,128

-29,044

-27,633

-25,727

-26,129

-24,097

-22,878

-21,670

-17,042

-16,059

0

0

0

Net loss per share of common stock outstanding, basic and diluted

-0.68

-0.41

-0.37

-0.39

-0.42

-0.35

-0.29

-30.60

-24.43

-23.34

-19.35

-16.58

-27.03

Weighted-average common shares outstanding, basic and diluted

18,681

18,627

18,508

18,351

18,026

17,655

17,382

245

226

211

194

173

167